IDNA Genomics Public Ltd (CYS:IDNA)

Cyprus · Delayed Price · Currency is EUR

14.80

0.00 (0.00%)

At close: Aug 31, 2026

-47.14% (1Y)

Market Cap	40.85M -47.1%
Revenue (ttm)	492.25K +3.0%
Net Income	-2.24M
EPS	-0.81
Shares Out	2.76M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Open	14.80
Previous Close	n/a
Day's Range	14.80 - 14.80
52-Week Range	14.80 - 34.40
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IDNA Genomics Public

IDNA Genomics Public Ltd engages in the field of genomics and biotechnology and specializes in personalized health care. The company develops and provides genetic tests in the field of genomics. It also develops and markets pharmaceutical products. The company was incorporated in 2020 and is based in Nicosia, Cyprus. [Read more]

Industry Medical Laboratories

Founded 2020

Employees 24

Stock Exchange Cyprus Stock Exchange

Ticker Symbol IDNA

Full Company Profile

Financial Performance

In 2025, IDNA Genomics Public's revenue was 492,252, an increase of 2.95% compared to the previous year's 478,148. Losses were -2.24 million, -11.30% less than in 2024.

Financial Statements